Anhui Huaheng Biotechnology Dividends and Buybacks
Dividend criteria checks 2/6
Anhui Huaheng Biotechnology is a dividend paying company with a current yield of 2.01% that is well covered by earnings.
Key information
2.0%
Dividend yield
0.5%
Buyback Yield
| Total Shareholder Yield | 2.5% |
| Future Dividend Yield | 3.7% |
| Dividend Growth | 5.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.621 |
| Payout ratio | 48% |
Recent dividend and buyback updates
No updates
Recent updates
Positive Sentiment Still Eludes Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Following 25% Share Price Slump
Jan 17
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Dec 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 688639 has been paying a dividend for less than 10 years.
Growing Dividend: 688639's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Anhui Huaheng Biotechnology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688639) | 2.0% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Chemicals) | 1.7% |
| Analyst forecast (688639) (up to 3 years) | 3.7% |
Notable Dividend: 688639's dividend (2.01%) is higher than the bottom 25% of dividend payers in the CN market (0.52%).
High Dividend: 688639's dividend (2.01%) is low compared to the top 25% of dividend payers in the CN market (2.05%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (47.8%), 688639's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 688639 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/14 22:32 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anhui Huaheng Biotechnology Co., Ltd. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tianhe Wang | China International Capital Corporation Limited |
| Chao Li | Citic Securities Co., Ltd. |
| Lin Yang | Guosen Securities Co., Ltd. |